Yu Li
1 Papers
Yu Li is an academic researcher. The author has contributed to research in topics: Internal medicine & Celecoxib. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression.
TL;DR: The results of the present study indicated that celecoxib ameliorated NASH in T2DM rats via suppression of the non-canonical Wnt5a/JNK1 signaling pathway expression.